l 2011
US
1821. BIOACTIVE AGENT FOR BONE TISSUE ENGINEERING
Abstract
Inventors have discovered a method for inducing bone formation in a patient in need thereof comprising administering an effective amount of benzoyladenosine-3′,5′-cyclic monophosphate (6-Bnz-cAMP) to...